
AVVH does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AVVH and 80,000+ other tickers.
See exactly how AVVH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AVVH and 80,000+ other tickers.
AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution of the over-the-counter Neuroskin product line. These treatments are formulated to address various skin irregularities and promote the natural clarity and texture of healthy skin, reaching consumers through conventional food and drug channels. Beyond its own brands, AVVAA also possesses distribution rights for a range of patented European skincare items. These…

AVVAA World Health Care Products, Inc. (OTCMKTS:AVVH - Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 7,500 shares, a growth of ∞ from the June 30th total of 0 shares. Based on an average daily volume of 351,834 shares,

Recaps 2025 Activities and Outlines Roadmap for 2026 HOUSTON, TX / ACCESS Newswire / December 16, 2025 / AVVAA World Health Care Products, Inc. (OTCID:AVVH) / GoldQuest Capital, Inc (the "Company") is pleased to provide shareholders with an update of recent activity and its near-term plans going forward. The Company has started funding loans secured by real estate and is working with private investors and multiple banks to expand our available capital to grow our portfolio.